3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Uterine Cervical Neoplasms
10
Neoplasms
9
Colorectal Neoplasms
6
Breast Neoplasms
6
Lung Neoplasms
5
Papillomavirus Infections
3
Uterine Cervical Dysplasia
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
HIV Infections
2
Esophageal Neoplasms
2
the Rate of Participation in Screening for PBC
1
Warts
1
Venous Thromboembolism
1
Uterine Cervical Diseases
1
Urinary Bladder Neoplasms
1
Tinea
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Skin Neoplasms
1
Retinoblastoma
1
Pulmonary Atelectasis
1
Postoperative Complications
1
Pneumonia
1
Pancreatic carcinoma, familial
1
Pancreatic cancer, adult
1
Oncology Problem
1
Nevus
1
Interventions
Cisplatin
109
Radiotherapy
100
Fluorouracil
90
Paclitaxel
75
Oxaliplatin
63
Docetaxel
56
Carboplatin
55
Irinotecan
41
Esophagectomy
41
Leucovorin
40
Capecitabine
39
Surgical Procedures, Operative
36
Radiation
36
Drug Therapy
31
Neoadjuvant Therapy
25
Chemoradiotherapy
18
Cetuximab
18
S 1 (combination)
17
pembrolizumab
16
camrelizumab
16
Nivolumab
15
Magnetic Resonance Spectroscopy
15
Bevacizumab
15
Blood Specimen Collection
14
Surveys and Questionnaires
12
Radiotherapy, Intensity-Modulated
12
Immunotherapy
11
Epirubicin
11
Biopsy
11
Trastuzumab
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Esophageal Neoplasms
×
Mass Screening
×
Clear all
NCT06335966
2026-03-17
BEST-RPP
OHSU Knight Cancer Institute
Active not recruiting
110 enrolled
NCT03461341
2020-03-26
ENSURE
St. James's Hospital, Ireland
Completed
3,000 enrolled